期刊文献+

绝经后女性冠心病患者性激素改变与血脂水平的研究 被引量:8

A study of sex hormone and lipid disorder in postmenopausal women with coronary heart disease
下载PDF
导出
摘要 目的探讨绝经后女性冠心病(CHD)患者性激素水平的变化及与血脂的关系。方法对30例绝经后女性CHD患者和30例绝经后女性正常对照者的血清总胆固醇(TC)、甘油三脂(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、雌二醇(E2)、孕酮(P)、睾酮(T)、卵泡刺激素(FSH)、促黄体生成素(LH)进行了检测。结果两组间年龄、绝经年数差异无显著性。绝经后女性CHD患者较正常对照组的E2、E/T、HDL-C明显降低(P<0.001、P=0.002、P =0.001),TC、TG、LDL-C增高(P=0.027、P=0.041、P<0.001),两组T、P无显著性差异(P>0.05)。相关分析表明绝经后女性CHD患者的E2与TC、TG、LDL-C 均呈显著负相关,与HDL-C呈显著正相关。E/T与TC、TG亦呈显著负相关。结论绝经后女性CHD患者血脂异常与雌激素水平明显降低有关,它们共同参与绝经后女性CHD的发生和发展。 Objective To study the changes of sex hormones in postmenopausal women with coronary'heart disease(CHD) and the relationship between sex hormones and lipids. Method the estradiol (E2) testosterone(T) pregnendione(P) follicle stimulating hormone(FSH) luteinizing honnone(LH) total cholesterol(TC) triglycerides(TG) low density lipoprotein(LDL) high density lipoprotein cholesterols(HDL) were measured in 30 postmenopausal women with CHD and 30 controls. Result The results showed that the E2,E/ T, HDL-C ratio were decreased (P<0.05) and TC,TG,LDL-C were elevated (P< 0.05) in postmenopausal with CHD group when compare to the control group. And T, P were the same (P>0.05). There were significant negative correlation between E2 and TC, TG,LDL- C and between E/T and TC,TG. There were significant positive correlation between E2 and HDL-C. Conclusion There is a close relationship between dyslipidenfia and the low level of E:m postmenopausal women. They play an important role in the development of CHD.
出处 《中国老年保健医学》 2005年第4期20-22,共3页 Chinese Journal of Geriatric Care
基金 广西南宁市2000年科研与技术开发计划(合同编号:20000234D)
关键词 冠心病 性激素 血脂 绝经妇女 Coronary Heart Disease, Sex Hormone,lipids, Postmenopausalwomen
  • 相关文献

参考文献7

二级参考文献14

  • 1吴瑞以,陈述林.健康老龄人群多种内分泌激素测定[J].山东医药,1993,33(10):12-13. 被引量:7
  • 2唐本雄,曹缵孙,毛文军.多囊卵巢综合征妇女激素与血脂水平的相关性研究[J].中国病理生理杂志,1993,9(4):523-526. 被引量:6
  • 3秦树存,王士雯,王琪,程云.雌激素对冠心病患者低密度脂蛋白受体基因表达的调节[J].中华内科杂志,1996,35(5):338-339. 被引量:18
  • 4刘仲萍 贺石林 李家增 主编.血栓性疾病的诊断与治疗[M].北京:人民卫生出版社,2000.263-265.
  • 5中华人民共和国卫生部.中国卫生统计提要[Z].北京:中华人民共和国卫生部,2000..
  • 6Giri S,Thompson PD,Taxel P,et al. Oral estrogen improves serum lipids,homocysteine and fibrinolysis in elderly men. Atherosclerosis, 1998, 137:359 - 366
  • 7Gao Wei, Tang Jian. Hyperhomocysteinemia:a new risk factor for many kinds of diseases: summary for national symposium on hyperhomocysteinemia and diseases. Chin Med J, 1999,79:1 - 5
  • 8Grodstein F, Stampfer M J, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med, 1996,335:453 - 461
  • 9Foster RH, Balfour JA. Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women. Drugs Aging, 1997,11: 309 - 332
  • 10Walsh BW, Schiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med, 1991,325: 1196 - 1204

共引文献196

同被引文献58

引证文献8

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部